tv p2-vp8
Vaccineexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Aug 15, 2019 (NCT04010448)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- RotavirusImmunity, active
Rotavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04010448 | Phase 3 | Aug 15, 2019 | Bill and Melinda Gates Foundation, Centre for Infectious Disease Research in Zambia (CIDRZ), PATH, SK Bioscience Co., Ltd., University of Ghana, University of Malawi |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Centre for Infectious Disease Research in Zambia (CIDRZ) | Academic/Hospital | 1 | 0 | 1 | 2019 |
| PATH | Academic/Hospital | 1 | 1 | 1 | 2019 |
| SK Bioscience Co., Ltd. | For profit | 1 | 0 | 1 | 2019 |
| University of Ghana | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Malawi | Academic/Hospital | 1 | 0 | 1 | 2019 |
6 organizations
Page 1 / 1